In the Clinic
By Julie Grisham, MS, Science Writer/Editor | Monday, July 16, 2012
Memorial Sloan-Kettering’s trial to evaluate a new therapy for patients with beta-thalassemia is the first to receive FDA approval to treat this disease with genetically engineered cells.
In the O.R.
By Jim Stallard, MA, Writer/Editor | Monday, July 9, 2012
Memorial Sloan-Kettering surgeons have pioneered a technique that may improve quality of life for women with early-stage gynecologic cancers.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Friday, July 6, 2012
A team of investigators from Memorial Sloan-Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.
By Memorial Sloan-Kettering | Monday, July 2, 2012
Pediatric Day Hospital Medical Director Farid Boulad explains that “we’re trying to excel at caring for the entire child, physically and emotionally.”
By Eva Kiesler, PhD, Science Writer/Editor and Irene Jarchum, PhD
Wednesday, June 27, 2012
In the largest study of genes and smoking performed in a minority population to date, researchers have discovered a gene variant that increases a person’s risk of smoking.
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor | Thursday, June 21, 2012
Memorial Sloan-Kettering investigators hope their new web tool will improve the accessibility of large-scale genome-sequencing information for cancer researchers everywhere, and accelerate research and therapeutic discovery.
By Memorial Sloan-Kettering | Wednesday, June 13, 2012
A May 11 ceremony recognized doctoral and honorary degree recipients and featured National Cancer Institute Director Harold Varmus as the keynote speaker.
By Memorial Sloan-Kettering | Tuesday, June 5, 2012
Memorial Sloan-Kettering and IBM have agreed to collaborate on the development of a powerful tool built upon IBM Watson to provide medical professionals with improved access to comprehensive cancer data and practices.
In the Clinic
By Media Staff | Monday, June 4, 2012
A new study confirms that female childhood cancer survivors who were treated with radiation to the chest have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes.
By Memorial Sloan-Kettering | Wednesday, May 30, 2012
Structural Biology Program Chair Nikola P. Pavletich and immunologist Alexander Y. Rudensky have received one of the highest honors given to scientists working in the United States.
By Allyson Collins, MS, Science Writer/Editor | Monday, May 21, 2012
In an interview, Dr. Bach talks about research showing that CT screening may prevent one in five cancer deaths for people at a very high risk of developing lung cancer.
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor | Monday, May 21, 2012
Results of an international study indicate that the investigational drug tivozanib is more effective and better tolerated than a currently approved therapy in delaying cancer growth.
By Memorial Sloan-Kettering | Friday, May 18, 2012
As part of Memorial Sloan-Kettering’s 33rd annual academic convocation on May 11, the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences awarded PhDs to four graduates.
By Media Staff | Thursday, May 17, 2012
Memorial Sloan-Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.
By Memorial Sloan-Kettering | Friday, May 11, 2012
Research at Memorial Sloan-Kettering will benefit from renewed support for The Starr Cancer Consortium and the Tri-Institutional Stem Cell Initiative totaling $105 million.